Evidence map›Paper›PMID 34949121›Full record

ArticleJournal of managed care & specialty pharmacy2022

Laboratory monitoring to reduce adverse drug-related events: a mixed methods study.

Teresa N Harrison, Kristi Reynolds, Erin E Hahn, Corrine E Munoz-Plaza, David K Yi, Heidi Fischer, Tiffany Q Luong, John J Sim, Jeffrey Brettler, Joel Handler and 4 more

Open access · greenAbstract read
In one paragraph

Article in Journal of managed care & specialty pharmacy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Guideline
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Teresa N HarrisonDepartment of Research & Evaluation, Kaiser Permanente Southern California, Pasadena.
Kristi ReynoldsDepartment of Research & Evaluation, Kaiser Permanente Southern California, and Department of Health Systems Science, Kaiser Permanente Bernard J Tyson School of Medicine, Pasadena, CA.
Erin E HahnDepartment of Research & Evaluation, Kaiser Permanente Southern California, Pasadena.
Corrine E Munoz-PlazaDepartment of Research & Evaluation, Kaiser Permanente Southern California, Pasadena.
David K YiDepartment of Research & Evaluation, Kaiser Permanente Southern California, Pasadena.
Heidi FischerDepartment of Research & Evaluation, Kaiser Permanente Southern California, Pasadena.
Tiffany Q LuongDepartment of Research & Evaluation, Kaiser Permanente Southern California, Pasadena.
John J SimDivision of Nephrology and Hypertension, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA.
Jeffrey BrettlerKaiser Permanente West Los Angeles Medical Center, Los Angeles, CA.
Joel HandlerSouthern California Permanente Medical Group, Yorba Linda.
Brian S MittmanDepartment of Research & Evaluation, Kaiser Permanente Southern California, Pasadena.
Hardeep SinghCenter for Innovations in Quality, Effectiveness and Safety, Michael E DeBakey VA Medical Center; Department of Medicine, Baylor College of Medicine, Houston, TX.
Michael H KanterDepartment of Clinical Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA.
Kim N DanforthDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena.
Kaiser Permanente · USKaiser Permanente West Los Angeles Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acute Kidney InjuryAgedAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsDrug-Related Side Effects and Adverse ReactionsElectronic Health RecordsFemaleHumansHyperkalemiaLaboratoriesMaleMiddle AgedRetrospective StudiesAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor Antagonists

Identifiers

PMID34949121
PMCPMC10398702
OpenAlexW4200490095

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.